Here are four insights:
1. The legislation is designed to ease FDA requirements.
2. The bills received bipartisan support.
3. Some opponents argue the legislation will prohibit the FDA from thoroughly inspecting the safety and efficacy of medical devices.
4. These bills are a piece of a larger National Institutes of Health initiative to increase medical research.
More articles on devices:
NuVasive receives Japanese approval for Reline posterior fixation technology: 5 notes
Nanovis wins NIH research grant for interbody fusion devices: 4 things to know
Wright Medical Group COO sells 13k+ shares: 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
